Mephenytoin Production Cost Reports

The report provides a detailed analysis essential for establishing a mephenytoin production plant. It encompasses all critical aspects necessary for mephenytoin production, including the cost of mephenytoin production, mephenytoin plant cost, mephenytoin production costs, and the overall mephenytoin production plant cost. Additionally, the study covers specific expenditures associated with setting up and operating a mephenytoin production plant. These encompass production processes, raw material requirements, utility requirements, infrastructure needs, machinery and technology requirements, manpower requirements, packaging requirements, transportation requirements, and more.

Mephenytoin is a hydantoin-class anticonvulsant drug that belongs to the phenyl hydantoin family. It has a hydantoin ring with a phenyl substituent. It stabilises neuronal membranes by blocking voltage- and frequency-dependent sodium channels in the motor cortex, reducing repetitive firing, post-tetanic potentiation, and seizure propagation. It is utilised in refractory partial epilepsy, grand mal, focal, Jacksonian, and psychomotor seizures in patients unresponsive to other options like phenytoin. It is used for mood stabilisation, pain management, or other conditions listed for similar drugs. Its use in epilepsy is regulated because of toxicity risks like aplastic anaemia.  Its common side effects include rash, nausea, ataxia, dizziness, and drowsiness.

The market for mephenytoin is driven by its demand in specialised epilepsy centres. Its usage for treating refractory partial, psychomotor, Jacksonian, and grand mal seizures that are unresponsive to first-line therapies like phenytoin contributes to its demand. Its efficacy in stabilising neuronal sodium channels to curb seizure propagation, along with rising epilepsy cases, fuels its market growth. The bulk sourcing from limited API manufacturers because of regulatory compliance for hospital formularies affects industrial mephenytoin procurement. The pricing pressures from generics and R&D costs for safer formulations impact scalability, along with clinician preference in high-risk cases influences its sourcing strategies.

Raw Material for Mephenytoin Production

According to the mephenytoin production plant project report, the key raw materials used in the production of mephenytoin include potassium cyanide, ammonium bicarbonate, and dimethyl sulfate.

Production Process of Mephenytoin

The extensive mephenytoin production cost report consists of the following major industrial production process:

1. From propiophenone: The production process for mephenytoin uses the Bucherer-Bergs reaction followed by selective methylation. The process starts with propiophenone, which is reacted with potassium cyanide and ammonium bicarbonate in an aqueous or alcoholic medium under reflux conditions. This forms the 5-ethyl-5-phenylhydantoin intermediate via imine formation, cyanohydrin addition, and cyclisation. This intermediate is then isolated or used directly and subjected to N-methylation using dimethyl sulfate in the presence of a base like sodium hydroxide in a solvent. This introduces the 3-methyl group at the hydantoin nitrogen, yielding mephenytoin. The product is purified by recrystallisation from ethanol or water to give pure mephenytoin as the final product.

Mephenytoin is a phenylhydantoin anticonvulsant with the molecular formula C12H14N2O2 and molecular weight of 218.25 g/mol. It appears as a solid crystalline powder with a melting point of 136-137 °C and is practically insoluble in water. It contains an imidazolidine-2,4-dione ring substituted with ethyl and phenyl groups at position 5 and a methyl group at nitrogen-3. It has one chiral centre and moderate lipophilicity with a logP value in the range 1.5-1.69. It has one hydrogen bond donor, two acceptors, and a topological polar surface area of 49.4 Ų. All these physical and chemical properties make it useful as an anticonvulsant drug.